SCHEMBL4501800

SCHEMBL4501800

Cc1cc2c(O)c(C(=O)O)c(=O)n(C)c2s1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.39
HSD17B10 Q99714 1/20 0.39
LDHA P00338 5/20 0.38
LDHB P07195 5/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.35
EGLN1 Q9GZT9 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
PGR P06401 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
ALB P02768 2/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
NLRP3 Q96P20 1/20 0.33
POLB P06746 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4502224 0.84 ALDH1A1 (0.41) ALDH1A1KDM4EMEN1KMT2ANPC1
SCHEMBL4518405 0.71 POLB (0.36) LDHALDHBALDH1A1MAPTPOLB
SCHEMBL4510951 0.70 FEN1 (0.51) LDHALDHBEGLN1L3MBTL1ALB
SCHEMBL4518939 0.69 ALDH1A1 (0.45) ALDH1A1KDM4EEGLN1L3MBTL1MEN1
SCHEMBL474786 0.68 KDM4E (0.37) HSD17B10ALDH1A1KDM4ERAB9AMAPT
SCHEMBL1685948 0.67 ALDH1A1 (0.77) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL4501941 0.67 NOTUM (0.32) ALDH1A1KDM4E
SCHEMBL8129315 0.67 KDM4E (0.47) HSD17B10LDHALDHBALDH1A1KDM4E
SCHEMBL11234096 0.67 KMT2A (0.44) HSD17B10LDHALDHBALDH1A1KDM4E
SCHEMBL31384761 0.66 LDHA (0.43) HSD17B10LDHALDHBALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553849-B2 Compounds ACTIVE BIOTECH AB (SE) 2009-06-30 US disclosed
EP-1776369-B1 THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE ACTIVE BIOTECH AB (SE) 2007-10-10 EP disclosed
US-20060004038-A1 Novel compounds ACTIVE BIOTECH AB (SE) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004038-A1 Novel compounds REL, CLIC4, C5 GFER 484/4885HSD17B10 2141/4885LDHA 4659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.